Paper32268136
Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment.
Yang SS and 7 others. Exp Cell Res, 2020. Cited by 146 papers, by iCite.
Cite this record
ConductScience Library. Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment. Papers, record 32268136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32268136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Breast Neoplasms | Major topic |
| Cancer-Associated Fibroblasts | Major topic |
| Exosomes | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| MicroRNAs | Major topic |
| Tumor Microenvironment | Major topic |
| Animals | |
| Apoptosis | |
| Carrier Proteins | |
| Cell Movement | |
| Cell Proliferation | |
| Female | |
| Humans | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Nude | |
| Neoplasm Invasiveness | |
| Neoplasm Metastasis | |
| Tumor Cells, Cultured | |
| Xenograft Model Antitumor Assays |
Source PubMed
Cited by110
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 146 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42936663 | Extracellular Vesicles in Breast Cancer: Immunomodulation, Biomarkers, and Therapy. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42936663 | PubMed |
| 42496815 | Treg-derived exosomal miR-146a orchestrates bidirectional Treg-CAF crosstalk to sustain immunosuppressive tumor microenvironments. | Med Oncol | 2026 | https://conductscience.org/library/papers/42496815 | PubMed |
| 42228917 | Whole-transcriptome sequencing reveals hypoxic esophageal squamous cell carcinoma-derived migrasomes driving cancer-associated fibroblast activation. | Brief Funct Genomics | 2026 | https://conductscience.org/library/papers/42228917 | PubMed |
| 41869398 | pH-Sensitive Long-Circulating Nanoliposomes with CU1 for Effective Against Lung Cancer. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/41869398 | PubMed |
| 41645802 | Exosomal HMGB1 Orchestrates NSCLC Progression and Immunosuppressive Macrophage Polarisation Through the TLR4/NF-κB/IL-6/STAT3 Signalling Cascade. | J Cell Mol Med | 2026 | https://conductscience.org/library/papers/41645802 | PubMed |
| 41463227 | MicroRNAs Modulating Cancer Immunotherapy Mechanisms and Therapeutic Synergies. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41463227 | PubMed |
| 41422355 | Functional role of cancer stem cell like exosomes on survival and drug resistance behaviors of colorectal cancer cells. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41422355 | PubMed |
| 41354919 | Exosomal regulation of cellular reprogramming and polarization in the tumor microenvironment. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/41354919 | PubMed |
| 41015590 | CAF-derived exosomes: orchestrators of dysregulated signaling pathways in breast cancer progression. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/41015590 | PubMed |
| 40776758 | Cancer‑associated fibroblasts in human malignancies, with a particular emphasis on sarcomas (Review). | Int J Oncol | 2025 | https://conductscience.org/library/papers/40776758 | PubMed |
| 40770502 | Mechanical regulation of extracellular vesicle activity during tumour progression. | Nat Biomed Eng | 2025 | https://conductscience.org/library/papers/40770502 | PubMed |
| 40711489 | Fibroblasts activated by miRs-185-5p, miR-652-5p, and miR-1246 shape the tumor microenvironment in triple-negative breast cancer via PATZ1 downregulation. | Cell Mol Life Sci | 2025 | https://conductscience.org/library/papers/40711489 | PubMed |
| 40682844 | Role of exosomal non‑coding RNAs in cancer‑associated fibroblast‑mediated therapy resistance (Review). | Int J Oncol | 2025 | https://conductscience.org/library/papers/40682844 | PubMed |
| 40629355 | Tumor-derived exosomes and their application in cancer treatment. | J Transl Med | 2025 | https://conductscience.org/library/papers/40629355 | PubMed |
| 40490663 | Exosomes in inflammation and cancer: from bench to bedside applications. | Mol Biomed | 2025 | https://conductscience.org/library/papers/40490663 | PubMed |
| 40241262 | p53 Deficiency in Colon Cancer Cells Promotes Tumor Progression Through the Modulation of Meflin in Fibroblasts. | Cancer Sci | 2025 | https://conductscience.org/library/papers/40241262 | PubMed |
| 40206796 | Extracellular vesicles and miRNA-based therapies in triple-negative breast cancer: advances and clinical perspectives. | Extracell Vesicles Circ Nucl Acids | 2025 | https://conductscience.org/library/papers/40206796 | PubMed |
| 40094065 | Advances in nanotechnology for targeting cancer-associated fibroblasts: A review of multi-strategy drug delivery and preclinical insights. | APL Bioeng | 2025 | https://conductscience.org/library/papers/40094065 | PubMed |
| 40079186 | Potential biological roles of exosomal non-coding RNAs in breast cancer. | FASEB J | 2025 | https://conductscience.org/library/papers/40079186 | PubMed |
| 40074317 | Role of exosomes in regulating ferroptosis of tumor cells. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2024 | https://conductscience.org/library/papers/40074317 | PubMed |
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AVPR2 | 554 | PubTator's text mining | https://conductscience.org/library/genes/554 | NCBI Gene |
| CD63 | 967 | PubTator's text mining | https://conductscience.org/library/genes/967 | NCBI Gene |
| CDH1 | 999 | PubTator's text mining | https://conductscience.org/library/genes/999 | NCBI Gene |
| CDH2 | 1000 | PubTator's text mining | https://conductscience.org/library/genes/1000 | NCBI Gene |
| MIR146A | 406938 | PubTator's text mining | https://conductscience.org/library/genes/406938 | NCBI Gene |
| PDCD6IP | 10015 | PubTator's text mining | https://conductscience.org/library/genes/10015 | NCBI Gene |
| SNAI1 | 6615 | PubTator's text mining | https://conductscience.org/library/genes/6615 | NCBI Gene |
| TSG101 | 7251 | PubTator's text mining | https://conductscience.org/library/genes/7251 | NCBI Gene |
| TXNIP | 10628 | PubTator's text mining | https://conductscience.org/library/genes/10628 | NCBI Gene |
| VIM | 7431 | PubTator's text mining | https://conductscience.org/library/genes/7431 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32268136
GET https://conductscience.org/api/papers/v1/32268136/cited_by?page=2